ROZANOLIXIZUMAB vs RUCAPARIB CAMSYLATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROZANOLIXIZUMAB vs RUCAPARIB CAMSYLATE: Safety Overview
| Metric | ROZANOLIXIZUMAB | RUCAPARIB CAMSYLATE |
|---|---|---|
| Total FAERS Reports | 303 | 8,240 |
| Deaths Reported | 9 | 448 |
| Death Rate | 3.0% | 5.4% |
| Hospitalizations | 114 | 1,148 |
| Average Patient Age | 61.3 yrs | 65.1 yrs |
| % Female Patients | 60.9% | 95.2% |
| FDA Approval Date | N/A | Dec 19, 2016 |
| Manufacturer | UCB, Inc. | pharmaand GmbH |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | N/A | Prescription |